rs2243250 — IL4 IL4 -589C>T

IL4 -589C>T — The Promoter Switch That Tilts the Immune System Toward Allergy

Your immune system must balance two broad modes of response: the Th1 mode, geared toward intracellular pathogens and inflammatory control, and the Th2 mode, oriented toward parasite defence, wound healing, and — in the modern environment — allergic reactions. The cytokine interleukin-4 (IL-4) is the master regulator of this Th2 arm. It drives naïve T cells toward Th2 differentiation, stimulates B cells to switch antibody production to IgE, and amplifies mast cell and eosinophil activity. The rs2243250 variant¹¹ rs2243250 variant
A single-letter DNA change 589 bases upstream of where IL4 gene transcription begins sits at a critical regulatory position in the IL4 promoter, and it is one of the best-studied immune polymorphisms in the allergy and asthma literature.

The Mechanism

The -589 position in the IL4 promoter falls within an inverted palindromic sequence (bases −603 to −588) that forms part of a binding site for NFAT-1²² NFAT-1
Nuclear Factor of Activated T cells — a transcription factor that enters the nucleus when T cells are stimulated and drives expression of cytokine genes. The C allele (reference) has lower affinity for NFAT-1 homodimers; the T allele subtly alters the palindrome geometry, increasing dimer binding affinity. The result is higher basal and stimulated IL-4 transcription in T carriers, leading to elevated serum IL-4 protein and downstream elevation of total serum IgE. This is not a dramatic loss-of-function change — it is a quantitative shift in the regulatory rheostat, which explains why the associations are probabilistic and population-level rather than deterministic.

The Evidence

The strongest evidence comes from a 2020 meta-analysis of 55 case-control studies³³ 2020 meta-analysis of 55 case-control studies
Kousha et al., BMC Immunology 2020 — 9,572 asthma cases and 9,881 controls across 49 publications covering 9,572 asthma cases and 9,881 controls. The T allele increased asthma risk across all genetic models tested: dominant model OR 1.22, recessive OR 1.17, and allelic OR 1.21. Subgroup analyses confirmed significance in both pediatric and adult cohorts and across Asian, American, and European populations, making this one of the most replicated allergy-related promoter polymorphisms in the literature.

For allergic rhinitis, a 2021 meta-analysis of 9 studies⁴⁴ 2021 meta-analysis of 9 studies
Jiang & Yan, Bioscience Reports 2021 — 1,709 allergic rhinitis patients found that TT homozygotes carried a 56% higher rhinitis risk compared to CC homozygotes (OR 1.56, 95% CI 1.13–2.17), with the allele model giving OR 1.19 (95% CI 1.04–1.35).

The IgE connection was directly quantified in a study of 500 asthmatic children⁵⁵ study of 500 asthmatic children
Li et al., Annals of Allergy, Asthma & Immunology 2014: children carrying multiple Th2-pathway risk alleles including rs2243250 showed mean IgE levels up to 902 KU/L compared to 71 KU/L in those with no risk alleles. A Filipino case-control study found the TT genotype specifically was associated with very high IgE (>1,000 IU/mL), OR 3.97 (p=0.016).

Evidence for atopic dermatitis is moderate — several studies show T allele enrichment in AD patients but effect sizes are smaller and replication is less consistent than for asthma. The Th2 mechanism is clearly relevant (IL-4 drives skin barrier disruption and IgE sensitization in AD), but the promoter SNP explains only a fraction of the genetic variance.

Practical Actions

For T carriers, the elevated Th2 tone means: (1) total serum IgE is a meaningful biomarker to track if allergic symptoms develop; (2) strategies that moderate Th2 skewing — such as quercetin supplementation, which demonstrably suppresses IL-4 transcription in activated T cells — have mechanistic relevance beyond generic anti-inflammatory advice; (3) allergen exposure management is especially worthwhile because this variant amplifies the IgE-sensitization response to initial exposures.

Interactions

This promoter variant operates in the same Th2 signalling axis as rs1801275 in IL4R (the IL-4 receptor alpha chain) and rs20541 in IL13 (interleukin-13, which shares the IL4Rα/IL-2Rγ receptor complex and has overlapping biological functions). Carriers of risk alleles at multiple loci in this pathway show multiplicative elevation of IgE and additive risk for asthma in gene-gene interaction studies. A four-locus model including rs2243250, IL13 rs20541, FCER1B, and ADRB2 demonstrates synergistic asthma susceptibility in Han Chinese children. rs2070874 (IL4 -33C/T), the second common IL4 promoter SNP, is in strong linkage disequilibrium with rs2243250 and should be considered in haplotype analyses — the CC haplotype at both sites is associated with inflammatory bowel disease risk while the TT haplotype tracks with atopic disease.